Battelle, AmplifyBio, Andelyn team up NIH contract targeting stroke, neurological disease


“If we can be part of bringing something like that to market – I think that’s a pretty big deal."

Previous 4 factors that will shape Orlando health care construction in 2023
Next Why early reading matters to the whole health of Georgia